Rani Therapeutics Holdings RANI
NASDAQ RANI
$0.82 +0.02 (+2.83%)
As of: Oct 2, 2026 · 11:01 AM EDT

Rani Therapeutics Holdings (RANI) Capital Expenditures (2020 - 2026)

Updated

Rani Therapeutics Holdings (RANI) posted Capital Expenditures of $32,000 for Q2 2026, down 13.5% from $37,000 a year earlier but up 113.3% from the prior quarter.

Analysis

Rani Therapeutics Holdings (RANI) Capital Expenditures (2020 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Rani Therapeutics Holdings was $47,000, down 80.7% year-over-year; for FY2025, it came in at $88,000, down 67.2% from FY2024.

  • Annual Capital Expenditures has declined for three consecutive years, with a five-year compound annual growth rate of -40.7% (FY2020 to FY2025).
  • In prior years, Rani Therapeutics Holdings' Capital Expenditures was $268,000 in FY2024 (-78.2%), $1.23 million in FY2023 (-24.1%), $1.62 million in FY2022 (+220.0%) and $506,000 in FY2021 (-57.8%).
  • Quarterly Capital Expenditures has run from a low of $15,000 in Q1 2026 to a high of $530,000 in Q4 2022 over five years.
  • On a year-over-year basis, Capital Expenditures increased in 1 of the last six quarters, with an average decline of 19.5%.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q1 2025, with growth of 183.3%; the weakest was Q1 2024, with a decline of 92.7%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Rani Therapeutics Holdings 147.86 Mn 156.61 Mn - 32,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 32,000.00
Mar 31, 2026 15,000.00
Jun 30, 2025 37,000.00
Mar 31, 2025 51,000.00
Dec 31, 2024 31,000.00
Sep 30, 2024 125,000.00
Jun 30, 2024 94,000.00
Mar 31, 2024 18,000.00
Dec 31, 2023 167,000.00
Sep 30, 2023 479,000.00
Jun 30, 2023 335,000.00
Mar 31, 2023 248,000.00
Dec 31, 2022 530,000.00
Sep 30, 2022 456,000.00
Jun 30, 2022 379,000.00
Mar 31, 2022 254,000.00
Dec 31, 2021 271,000.00
Jun 30, 2021 136,000.00
Mar 31, 2021 99,000.00
Dec 31, 2020 256,000.00
API Access

Rani Therapeutics Holdings Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=RANI&period=max&api_key=YOUR_API_KEY